Sanofi Consumer Healthcare India Limited has submitted the Exchange Voting Results and Consolidated Scrutinizers Report of 2nd Annual General Meeting held on May 05, 2025
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India Limited submitted the voting results and consolidated scrutinizer's report for its 2nd AGM held on May 5, 2025, with 53,563 shareholders on record as of April 28, 2025. All seven resolutions were passed with overwhelming majority, including adoption of audited financial statements for FY ended December 31, 2024, declaration of a final dividend of ₹55 per equity share (on face value of ₹10), re-appointment of Ms. Carol-Ann Stewart and Mr. Himanshu Bakshi as directors (retiring by rotation), ratification of cost auditor remuneration, appointment of secretarial auditor, and payment of commission to non-executive directors. Total votes polled were 20,295,831 shares representing 88.13% of the 23,030,622 outstanding shares, with promoter group (13,909,587 shares) voting 100% in favour of all resolutions.
The ₹55 per share dividend (550% on face value) is a positive cash return for shareholders, reflecting strong FY2024 performance. With all resolutions passing by near-unanimous votes and no contentious issues raised, this is a routine regulatory filing with no expected negative impact on the stock price.